COVID-19: FDA warns against side effects of hydroxychloroqui
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The US Food and Drug Administration has issued a safety communication regarding the known side effects of antimalarial drug hydroxychloroquine for treating coronavirus patients. The side effects include serious and potentially life-threatening heart rhythm problems.

These risks are already in the drug labels for their approved uses and may be mitigated when health care professionals closely screen and supervise these patients.

As of now, it has issued an emergency use authorization to allow hydroxychloroquine and chloroquine products to be distributed and used in limited circumstances, such as for certain hospitalized patients with COVID-19.

The EUA requires that fact sheets with important information about using these drugs in treating COVID-19, including the known risks and drug interactions, as well as appropriate screening and monitoring, be made available to health care providers and patients, FDA said.

Hydroxychloroquine and chloroquine are FDA-approved to treat or prevent malaria. Hydroxychloroquine sulfate is also FDA-approved to treat lupus and rheumatoid arthritis.

FDA said these medicines have not been proven safe or effective for treating COVID-19. However, clinical trials are underway and additional trials are being planned to determine if these drugs can benefit patients with COVID-19.

These trials are also examining whether the drugs can prevent COVID-19 among health care workers, first responders, or people who have been in close contact with someone with COVID-19. Reports indicate that the malaria drug has been effective during the initial phases of a person being infected by coronavirus but poses dangers to those having heart ailments.

Source: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or
N●●a R●●●●●r and 14 others like this14 shares
Like
Comment
Share
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
Then can somebody please remind us all why are we giving patients and health care workers hydroxychloroquine ??? Hahaha.
Apr 25, 2020Like2
Dr. M●●●●●v D●●●i
Dr. M●●●●●v D●●●i Internal Medicine
Jury for HCQ is not yet out. The QT prolongation side effect is real but not in larger number as it is made out, none the less prior to starting HCQ should be taken to make sure that QT interval is less than 440 milliseconds. This is important in elderly and in patients with preexisting CAD. I would say it is individual Doctor' s call as far as prophylaxis use, but for therapeutic use, it is a part of Standard of care by the guidelines issued by mohf,GOI. I personally have been taking HCQs 400 mg every week.... Read more
May 9, 2020Like